Glenmark Hit With $50M Suit Over Potassium Pill Death
By Mike Curley · September 3, 2024, 2:38 PM EDT
A proposed class of buyers is suing Glenmark Pharmaceuticals Inc. for more than $50 million, alleging that the company's extended-release potassium chloride capsules are defective and instead deliver the potassium too...
To view the full article, register now.